{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:11:40Z","timestamp":1792595500673,"version":"4.5.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T00:00:00Z","timestamp":1731715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Alz Res Therapy"],"DOI":"10.1186\/s13195-024-01617-2","type":"journal-article","created":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T10:42:33Z","timestamp":1731753753000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Age of onset moderates the effects of Vascular Risk Factors on Neurodegeneration, Blood-Brain-Barrier permeability, and cognitive decline in Alzheimer\u2019s Disease"],"prefix":"10.1186","volume":"16","author":[{"given":"Chiara Giuseppina","family":"Bonomi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina Gaia","family":"Di Donna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Nuccetelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Bernardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola Biagio","family":"Mercuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Martorana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,11,16]]},"reference":[{"key":"1617_CR1","unstructured":"Alzheimer\u2019s Disease International. World Alzheimer Report 2023: Reducing Dementia Risk: Never too early, never too late. 2023."},{"issue":"8","key":"1617_CR2","first-page":"8","volume":"2","author":"H Hampel","year":"2022","unstructured":"Hampel H, Au R, Mattke S, van der Flier WM, Aisen P, Apostolova L, et al. Designing the next-generation clinical care pathway for Alzheimer\u2019s disease. Nat Aging 2022. 2022;2(8):8.","journal-title":"Nat Aging 2022"},{"issue":"7","key":"1617_CR3","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1093\/brain\/awy153","volume":"141","author":"EJ Coulthard","year":"2018","unstructured":"Coulthard EJ, Love S. A broader view of dementia: multiple co-pathologies are the norm. Brain. 2018;141(7):1894\u20137.","journal-title":"Brain"},{"issue":"7","key":"1617_CR4","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1093\/brain\/awy146","volume":"141","author":"JL Robinson","year":"2018","unstructured":"Robinson JL, Lee EB, Xie SX, Rennert L, Suh E, Bredenberg C, et al. Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated. Brain. 2018;141(7):2181\u201393.","journal-title":"Brain"},{"issue":"5","key":"1617_CR5","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/j.bbadis.2015.12.023","volume":"1862","author":"A Kapasi","year":"2016","unstructured":"Kapasi A, Schneider JA. Vascular contributions to cognitive impairment, clinical Alzheimer\u2019s disease, and dementia in older persons. Biochim et Biophys Acta - Mol Basis Disease. 2016;1862(5):878\u201386.","journal-title":"Biochim et Biophys Acta - Mol Basis Disease"},{"key":"1617_CR6","doi-asserted-by":"crossref","unstructured":"Coomans EM, van Westen D, Pichet Binette A, Strandberg O, Spotorno N, Serrano GE et al. Interactions between vascular burden and amyloid-\u03b2 pathology on trajectories of tau accumulation. Brain. 2023.","DOI":"10.1093\/brain\/awad317"},{"key":"1617_CR7","doi-asserted-by":"crossref","unstructured":"Cogswell PM, Lundt ES, Therneau TM, Mester CT, Wiste HJ, Graff-Radford J et al. Evidence against a temporal association between cerebrovascular disease and Alzheimer\u2019s disease imaging biomarkers. Nature Communications 2023 14:1. 2023;14(1):1\u201312.","DOI":"10.1038\/s41467-023-38878-8"},{"issue":"4","key":"1617_CR8","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1016\/j.jalz.2013.12.025","volume":"11","author":"KJ Bangen","year":"2015","unstructured":"Bangen KJ, Nation DA, Delano-Wood L, Weissberger GH, Hansen LA, Galasko DR, et al. Aggregate effects of vascular risk factors on cerebrovascular changes in autopsy-confirmed Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2015;11(4):394\u2013e4031.","journal-title":"Alzheimer\u2019s Dement"},{"key":"1617_CR9","doi-asserted-by":"publisher","first-page":"618986","DOI":"10.3389\/fncel.2020.618986","volume":"14","author":"J Steinman","year":"2021","unstructured":"Steinman J, Sun HS, Feng ZP. Microvascular alterations in Alzheimer\u2019s Disease. Front Cell Neurosci. 2021;14:618986.","journal-title":"Front Cell Neurosci"},{"issue":"1","key":"1617_CR10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.jalz.2018.07.222","volume":"15","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, et al. Vascular dysfunction\u2014the disregarded partner of Alzheimer\u2019s disease. Alzheimer\u2019s Dement. 2019;15(1):158\u201367.","journal-title":"Alzheimer\u2019s Dement"},{"issue":"1","key":"1617_CR11","first-page":"1","volume":"7","author":"Y Iturria-Medina","year":"2016","unstructured":"Iturria-Medina Y, Sotero RC, Toussaint PJ, Mateos-P\u00e9rez JM, Evans AC, Weiner MW, et al. Early role of vascular dysregulation on late-onset Alzheimer\u2019s disease based on multifactorial data-driven analysis. Nat Commun 2016. 2016;7(1):1.","journal-title":"Nat Commun 2016"},{"issue":"2","key":"1617_CR12","first-page":"2","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation DA, Sweeney MD, Montagne A, Sagare AP, D\u2019Orazio LM, Pachicano M, et al. Blood\u2013brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med 2019. 2019;25(2):2.","journal-title":"Nat Med 2019"},{"issue":"2","key":"1617_CR13","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1038\/s44161-021-00014-4","volume":"1","author":"G Barisano","year":"2022","unstructured":"Barisano G, Montagne A, Kisler K, Schneider JA, Wardlaw JM, Zlokovic BV. Blood-brain barrier link to human cognitive impairment and Alzheimer\u2019s Disease. Nat Cardiovasc Res. 2022;1(2):108.","journal-title":"Nat Cardiovasc Res"},{"key":"1617_CR14","doi-asserted-by":"crossref","unstructured":"Puig-Pijoan A, Jimenez-Balado J, Fern\u00e1ndez-Lebrero A, Garc\u00eda-Escobar G, Navalpotro-G\u00f3mez I, Contador J, et al. Risk of cognitive decline progression is associated to increased blood-brain-barrier permeability: a longitudinal study in a memory unit clinical cohort. Alzheimer\u2019s & Dementia; 2023.","DOI":"10.1002\/alz.13433"},{"issue":"1","key":"1617_CR15","doi-asserted-by":"publisher","first-page":"39","DOI":"10.3233\/JAD-190764","volume":"73","author":"JT He","year":"2020","unstructured":"He JT, Zhao X, Xu L, Mao CY. Vascular risk factors and Alzheimer\u2019s Disease: blood-brain barrier disruption, metabolic syndromes, and Molecular Links. J Alzheimer\u2019s Disease. 2020;73(1):39\u201358.","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"6","key":"1617_CR16","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1016\/j.jalz.2014.10.008","volume":"11","author":"HM Snyder","year":"2015","unstructured":"Snyder HM, Corriveau RA, Craft S, Faber JE, Greenberg SM, Knopman D, et al. Vascular contributions to cognitive impairment and dementia including Alzheimer\u2019s disease. Alzheimer\u2019s Dementia: J Alzheimer\u2019s Association. 2015;11(6):710\u20137.","journal-title":"Alzheimer\u2019s Dementia: J Alzheimer\u2019s Association"},{"issue":"23","key":"1617_CR17","doi-asserted-by":"publisher","first-page":"e3093","DOI":"10.1212\/WNL.0000000000010946","volume":"95","author":"C Pettigrew","year":"2020","unstructured":"Pettigrew C, Soldan A, Wang J, Wang MC, Arthur K, Moghekar A, et al. Association of midlife vascular risk and AD biomarkers with subsequent cognitive decline. Neurology. 2020;95(23):e3093\u2013103.","journal-title":"Neurology"},{"issue":"9","key":"1617_CR18","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1001\/jamaneurol.2018.1123","volume":"75","author":"JS Rabin","year":"2018","unstructured":"Rabin JS, Schultz AP, Hedden T, Viswanathan A, Marshall GA, Kilpatrick E, et al. Interactive associations of vascular risk and \u03b2-Amyloid Burden with Cognitive decline in clinically normal Elderly individuals: findings from the Harvard Aging Brain Study. JAMA Neurol. 2018;75(9):1124\u201331.","journal-title":"JAMA Neurol"},{"issue":"22","key":"1617_CR19","doi-asserted-by":"publisher","first-page":"2302","DOI":"10.1056\/NEJMoa0806142","volume":"360","author":"GM Savva","year":"2009","unstructured":"Savva GM, Wharton SB, Ince PG, Forster G, Matthews FE, Brayne C. Age, neuropathology, and dementia. N Engl J Med. 2009;360(22):2302\u20139.","journal-title":"N Engl J Med"},{"issue":"14","key":"1617_CR20","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1001\/jama.2017.3090","volume":"317","author":"RF Gottesman","year":"2017","unstructured":"Gottesman RF, Schneider ALC, Zhou Y, Coresh J, Green E, Gupta N, et al. Association between midlife vascular risk factors and estimated brain amyloid deposition. JAMA. 2017;317(14):1443\u201350.","journal-title":"JAMA"},{"issue":"7","key":"1617_CR21","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1093\/brain\/awab099","volume":"144","author":"S Spina","year":"2021","unstructured":"Spina S, La Joie R, Petersen C, Nolan AL, Cuevas D, Cosme C, et al. Comorbid neuropathological diagnoses in early versus late-onset Alzheimer\u2019s disease. Brain. 2021;144(7):2186\u201398.","journal-title":"Brain"},{"key":"1617_CR22","doi-asserted-by":"crossref","unstructured":"Wang YT, Therriault J, Servaes S, Tissot C, Rahmouni N, Macedo AC et al. Sex-specific modulation of amyloid-\u03b2 on tau phosphorylation underlies faster tangle accumulation in females. Brain. 2023.","DOI":"10.1002\/alz.078657"},{"issue":"4","key":"1617_CR23","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1007\/s11135-017-0584-6","volume":"52","author":"R Johnston","year":"2018","unstructured":"Johnston R, Jones K, Manley D. Confounding and collinearity in regression analysis: a cautionary tale and an alternative procedure, illustrated by studies of British voting behaviour. Qual Quantity. 2018;52(4):1957\u201376.","journal-title":"Qual Quantity"},{"key":"1617_CR24","doi-asserted-by":"crossref","unstructured":"Sapkota S, Erickson K, Fletcher E, Tomaszewski Farias SE, Jin LW, DeCarli C. Vascular Risk Predicts Plasma Amyloid \u03b2 42\/40 Through Cerebral Amyloid Burden in Apolipoprotein E \u03b54 Carriers. Stroke [Internet]. 2023 May 1 [cited 2023 Jun 9];54(5):1227\u201335. https:\/\/pubmed.ncbi.nlm.nih.gov\/37021572\/","DOI":"10.1161\/STROKEAHA.122.041854"},{"issue":"3","key":"1617_CR25","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/archneurol.2008.596","volume":"66","author":"T Tapiola","year":"2009","unstructured":"Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, et al. Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain. Arch Neurol. 2009;66(3):382\u20139.","journal-title":"Arch Neurol"},{"issue":"5","key":"1617_CR26","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1002\/ana.25071","volume":"82","author":"P Vemuri","year":"2017","unstructured":"Vemuri P, Lesnick TG, Przybelski SA, Knopman DS, Lowe VJ, Graff-Radford J, et al. Age, vascular health, and Alzheimer disease biomarkers in an elderly sample. Ann Neurol. 2017;82(5):706\u201318.","journal-title":"Ann Neurol"},{"issue":"9","key":"1617_CR27","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1056\/NEJMoa1202753","volume":"367","author":"RJ Bateman","year":"2012","unstructured":"Bateman RJ, Xiong C, Benzinger TLS, Fagan AM, Goate A, Fox NC, et al. Clinical and biomarker changes in dominantly inherited Alzheimer\u2019s disease. N Engl J Med. 2012;367(9):795\u2013804.","journal-title":"N Engl J Med"},{"issue":"1","key":"1617_CR28","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1177\/0891988706297086","volume":"20","author":"GA Marshall","year":"2007","unstructured":"Marshall GA, Fairbanks LA, Tekin S, Vinters HV, Cummings JL. Early-onset Alzheimer\u2019s disease is associated with greater pathologic burden. J Geriatr Psychiatr Neurol. 2007;20(1):29\u201333.","journal-title":"J Geriatr Psychiatr Neurol"},{"issue":"2","key":"1617_CR29","first-page":"122","volume":"1","author":"K Ritchie","year":"2015","unstructured":"Ritchie K, Ritchie CW, Jaffe K, Skoog I, Scarmeas N. Is late-onset Alzheimer\u2019s disease really a disease of midlife? Alzheimer\u2019s & dementia: Translational Research &. Clin Interventions. 2015;1(2):122.","journal-title":"Clin Interventions"},{"key":"1617_CR30","doi-asserted-by":"crossref","unstructured":"Boivin-Proulx LA, Brouillette J, Dorais M, Perreault S. Association between cardiovascular diseases and dementia among various age groups: a population-based cohort study in older adults. Sci Rep. 2023;13(1).","DOI":"10.1038\/s41598-023-42071-8"},{"issue":"3","key":"1617_CR31","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1161\/STROKEAHA.122.040578","volume":"54","author":"AV Andjelkovic","year":"2023","unstructured":"Andjelkovic AV, Situ M, Citalan-Madrid AF, Stamatovic SM, Xiang J, Keep RF. Blood-brain barrier dysfunction in normal aging and neurodegeneration: mechanisms, impact, and treatments. Stroke. 2023;54(3):661\u201372.","journal-title":"Stroke"},{"issue":"12","key":"1617_CR32","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1093\/brain\/awaa325","volume":"143","author":"BM Tijms","year":"2020","unstructured":"Tijms BM, Gobom J, Reus L, Jansen I, Hong S, Dobricic V, et al. Pathophysiological subtypes of Alzheimer\u2019s disease based on cerebrospinal fluid proteomics. Brain. 2020;143(12):3776\u201392.","journal-title":"Brain"},{"issue":"Preprint","key":"1617_CR33","first-page":"1","volume":"Preprint","author":"F Ricci","year":"2023","unstructured":"Ricci F, Martorana A, Bonomi CG, Serafini C, Mercuri NB, Koch G, et al. Effect of vascular risk factors on blood-brain barrier and cerebrospinal fluid biomarkers along the Alzheimer\u2019s Disease Continuum: a retrospective observational study. J Alzheimer\u2019s Disease. 2023;Preprint(Preprint):1\u20139.","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"1","key":"1617_CR34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-019-0546-4","volume":"12","author":"YW Cheng","year":"2020","unstructured":"Cheng YW, Chiu MJ, Chen YF, Cheng TW, Lai YM, Chen TF. The contribution of vascular risk factors in neurodegenerative disorders: from mild cognitive impairment to Alzheimer\u2019s disease. Alzheimer\u2019s Res Therapy. 2020;12(1):1\u201310.","journal-title":"Alzheimer\u2019s Res Therapy"},{"issue":"1","key":"1617_CR35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-020-00736-w","volume":"13","author":"J Kim","year":"2021","unstructured":"Kim J, Woo SY, Kim S, Jang H, Kim J, Kim J, et al. Differential effects of risk factors on the cognitive trajectory of early- and late-onset Alzheimer\u2019s disease. Alzheimer\u2019s Res Therapy. 2021;13(1):1\u201310.","journal-title":"Alzheimer\u2019s Res Therapy"},{"issue":"8","key":"1617_CR36","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1002\/acn3.51824","volume":"10","author":"X Luo","year":"2023","unstructured":"Luo X, Hong H, Li K, Zeng Q, Wang S, Li Z, et al. Distinct cerebral small vessel disease impairment in early- and late-onset Alzheimer\u2019s disease. Ann Clin Transl Neurol. 2023;10(8):1326\u201337.","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"1617_CR37","doi-asserted-by":"publisher","first-page":"619","DOI":"10.3233\/JAD-150109","volume":"47","author":"E Hessen","year":"2015","unstructured":"Hessen E, Nordlund A, Stalhammar J, Eckerstr\u00f6m M, Bjerke M, Eckerstr\u00f6m C, et al. T-Tau is Associated with Objective memory decline over two years in persons seeking help for subjective cognitive decline: a report from the Gothenburg-Oslo MCI Study. J Alzheimer\u2019s Disease. 2015;47(3):619\u201328.","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"1","key":"1617_CR38","doi-asserted-by":"publisher","first-page":"e16095","DOI":"10.1111\/ene.16095","volume":"31","author":"M Bruno","year":"2024","unstructured":"Bruno M, Bonomi CG, Ricci F, Di Donna MG, Mercuri NB, Koch G, et al. Blood\u2013brain barrier permeability is associated with different neuroinflammatory profiles in Alzheimer\u2019s disease. Eur J Neurol. 2024;31(1):e16095.","journal-title":"Eur J Neurol"},{"issue":"2","key":"1617_CR39","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3390\/brainsci13020218","volume":"13","author":"DG Ali","year":"2023","unstructured":"Ali DG, Abner EL, Bahrani AA, El Khouli R, Gold BT, Jiang Y, et al. Amyloid-PET and White Matter Hyperintensities have Independent effects on Baseline cognitive function and synergistic effects on Longitudinal executive function. Brain Sci. 2023;13(2):218.","journal-title":"Brain Sci"},{"issue":"1","key":"1617_CR40","doi-asserted-by":"publisher","first-page":"25724","DOI":"10.1161\/JAHA.122.025724","volume":"12","author":"M Ruthirakuhan","year":"2023","unstructured":"Ruthirakuhan M, Cogo-Moreira H, Swardfager W, Herrmann N, Lanctot KL, Black SE. Cardiovascular Risk factors and risk of Alzheimer Disease and Mortality: a latent class Approach. J Am Heart Association. 2023;12(1):25724.","journal-title":"J Am Heart Association"},{"issue":"9984","key":"1617_CR41","doi-asserted-by":"publisher","first-page":"2255","DOI":"10.1016\/S0140-6736(15)60461-5","volume":"385","author":"T Ngandu","year":"2015","unstructured":"Ngandu T, Lehtisalo J, Solomon A, Lev\u00e4lahti E, Ahtiluoto S, Antikainen R, et al. A 2 year multidomain intervention of diet, exercise, cognitive training, and vascular risk monitoring versus control to prevent cognitive decline in at-risk elderly people (FINGER): a randomised controlled trial. Lancet. 2015;385(9984):2255\u201363.","journal-title":"Lancet"}],"container-title":["Alzheimer's Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01617-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13195-024-01617-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13195-024-01617-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,16]],"date-time":"2024-11-16T11:03:02Z","timestamp":1731754982000},"score":1,"resource":{"primary":{"URL":"https:\/\/alzres.biomedcentral.com\/articles\/10.1186\/s13195-024-01617-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,16]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["1617"],"URL":"https:\/\/doi.org\/10.1186\/s13195-024-01617-2","relation":{},"ISSN":["1758-9193"],"issn-type":[{"value":"1758-9193","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,16]]},"assertion":[{"value":"26 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 November 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants or legal representatives signed a written informed consent for the anonymization, storage, and analysis of all clinical and biological data. The Ethics committee of the Policlinico Tor Vergata in Rome reviewed and approved this study, which was conducted according to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"248"}}